TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33606908

Group type: EXPERIMENTAL
Intervention: iGlarLixi once daily
Number of subjects: 887

Group type: COMPARATOR
Intervention: BIAsp 30 twice daily
Number of subjects: 887
Study: 32825849

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: All AMs combined
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: General AM use
Number of subjects: 808
Study: 35300622

Group type: EXPERIMENTAL
Intervention: Active intervention (low-frequency rTMS and cathodal tDCS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 10
Study: 34716033

Group type: EXPERIMENTAL
Intervention: Aerobic physical activity intervention (14-week, 4 lessons per week)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Cognitively-engaging physical activity intervention (14-week, 4 lessons per week)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (regular program, 2 lessons per week)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: All groups (aerobic, cognitively-engaging, control)
Number of subjects: 62
Study: 34601896

Group type: EXPERIMENTAL
Intervention: PCSK9 association with HDL
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: Postprandial response studies
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: HDL proteome analysis
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: Mechanistic study of HDL and PCSK9
Number of subjects: 656
Study: 35844458

Group type: EXPERIMENTAL
Intervention: Inhalation of 7% sevoflurane and intravenous infusion of remifentanil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Inhalation of 7% sevoflurane
Number of subjects: 60
Study: 33694325

Group type: EXPERIMENTAL
Intervention: Stylosanthes hamata (SH)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Deep litter (DL)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Stylosanthes hamata (SH), Stylosanthes guanensis (SG), Mucuna pruriens (MP)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Deep litter (DL) and free run (FR)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Legume pastures
Number of subjects: 200
Study: 35041082

Group type: EXPERIMENTAL
Intervention: EBPT
Number of subjects: 60

Group type: COMPARATOR
Intervention: PO-EBPT
Number of subjects: 60
Study: 34537218

Group type: EXPERIMENTAL
Intervention: Point-of-Care Testing (POCT)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Central laboratory
Number of subjects: 380
Study: 33871235

Group type: EXPERIMENTAL
Intervention: Treated group (with occlusal splint)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (Untreated)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo group (lower plaque without occlusal coverage)
Number of subjects: 16
Study: 32854761

Group type: EXPERIMENTAL
Intervention: Guideline therapy plus TCMR (acupressure therapy and Liu Zi Jue Qigong exercises)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Guideline therapy (control group)
Number of subjects: 128
Study: 35940019

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 76
Study: 33476482

Group type: EXPERIMENTAL
Intervention: Adherence to infection control and prevention (ICP) guidelines
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Adherence to wearing medical masks, gloves, and hand hygiene practices
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Factors contributing to high-risk exposure
Number of subjects: 552
Study: 32551271

Group type: EXPERIMENTAL
Intervention: Coblation adenoidectomy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional adenoidectomy
Number of subjects: 70
Study: 35482125

Group type: EXPERIMENTAL
Intervention: Open-release surgery
Number of subjects: 62

Group type: COMPARATOR
Intervention: Ultrasound-guided tendon dry needling
Number of subjects: 62
Study: 33798466

Group type: EXPERIMENTAL
Intervention: Volanesorsen (300 mg subcutaneously once a week for 26 weeks, then every 2 weeks)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo (1.5 mL subcutaneously once a week for 26 weeks, then every 2 weeks)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Volanesorsen
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 36400420

Group type: EXPERIMENTAL
Intervention: Intrapartum ultrasound for labor progress assessment
Number of subjects: 182
Study: 33334727

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 498

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 498
Study: 32242480

Group type: EXPERIMENTAL
Intervention: High-frequency external muscle stimulation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 22
Study: 33137579

Group type: EXPERIMENTAL
Intervention: SPEEDI intervention (10 therapy sessions until 3 months' corrected age, 5 hospital sessions and 5 home-based sessions)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 17
Study: 36484441

Group type: EXPERIMENTAL
Intervention: 10-μg TAK-426 vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Natural infection
Number of subjects: 0
Study: 34211101

Group type: EXPERIMENTAL
Intervention: Photoneuromodulation (PNM) stimulation applied to the forehead
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham stimulation (control group)
Number of subjects: 33
Study: 34904903

Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion during cardiopulmonary bypass
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-pulsatile perfusion during cardiopulmonary bypass
Number of subjects: 70
Study: 34351598

Group type: EXPERIMENTAL
Intervention: Voluntary decision support for CT imaging of patients with head injuries
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Voluntary decision support for CT imaging of patients with suspected pulmonary embolism
Number of subjects: 225
Study: 36150063

Group type: EXPERIMENTAL
Intervention: Baseline pain
Number of subjects: 7237

Group type: EXPERIMENTAL
Intervention: Baseline elevated depressive symptoms
Number of subjects: 7237
Study: 33858553

Group type: EXPERIMENTAL
Intervention: Empiric antibiotics for MRSA infection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-MRSA antibiotics
Number of subjects: 0
Study: 32800062

Group type: EXPERIMENTAL
Intervention: Real-world evidence (RWE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 34614379

Group type: EXPERIMENTAL
Intervention: Liquid MenACWY-CRM vaccine presentation stored for approximately 24 months
Number of subjects: 1690

Group type: EXPERIMENTAL
Intervention: Liquid MenACWY-CRM vaccine presentation stored for approximately 30 months
Number of subjects: 1690

Group type: COMPARATOR
Intervention: Licensed lyophilized/liquid MenACWY-CRM vaccine presentation
Number of subjects: 1690
Study: 33887722

Group type: EXPERIMENTAL
Intervention: MedTest Coronavirus (COVID-19) IgG/IgM
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: COVID-19 IgG/IgM ECO Test
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Camtech COVID-19 IgM/IgG Rapid Test Kit
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 1-Step COVID-19 Test for total antibodies
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Wondfo test
Number of subjects: 119

Group type: COMPARATOR
Intervention: Probable SARS-CoV-2 infection cases
Number of subjects: 119
Study: 32169137

Group type: EXPERIMENTAL
Intervention: Fiber reinforced composite (FRC) retainers
Number of subjects: 54

Group type: COMPARATOR
Intervention: Multistranded stainless steel (MSW) retainers
Number of subjects: 54
Study: 35377919

Group type: EXPERIMENTAL
Intervention: Mental health-focused intervention
Number of subjects: 723
Study: 34778734

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) PEP (400/100 mg) twice daily for 5 days
Number of subjects: 318

Group type: COMPARATOR
Intervention: Surveillance (no PEP)
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) PEP
Number of subjects: 318
Study: 35987857

Group type: EXPERIMENTAL
Intervention: Expert assessment of shoulder impairments followed by an individualised treatment plan
Number of subjects: 130

Group type: COMPARATOR
Intervention: Minimal physiotherapeutic rehabilitation program delivered in a pamphlet
Number of subjects: 130
Study: 35648426

Group type: EXPERIMENTAL
Intervention: EGCG solution (660 μmol/L)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl saline)
Number of subjects: 180
Study: 34365061

Group type: EXPERIMENTAL
Intervention: Propolis (500 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32859661

Group type: EXPERIMENTAL
Intervention: Dietary intervention to increase high-nitrate vegetable consumption and reduce salt intake over 6 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 0
Study: 34342807

Group type: EXPERIMENTAL
Intervention: Smartphone app-directed and nurse-supported self-management intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 32128877

Group type: EXPERIMENTAL
Intervention: Low-dose SIM (200 mg)
Number of subjects: 400

Group type: COMPARATOR
Intervention: High-dose SIM (1200 mg)
Number of subjects: 400
Study: 35638295

Group type: EXPERIMENTAL
Intervention: Narrowband ultraviolet B (NB-UVB) phototherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo phototherapy
Number of subjects: 30
Study: 34028866

Group type: EXPERIMENTAL
Intervention: EMPWR program (2-session STI risk reduction program)
Number of subjects: 150
Study: 32390721

Group type: EXPERIMENTAL
Intervention: Pre-exercise maltodextrin (2g/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no maltodextrin)
Number of subjects: 0
Study: 35834000

Group type: EXPERIMENTAL
Intervention: Mozart's music during toothbrushing training
Number of subjects: 60

Group type: COMPARATOR
Intervention: No music during toothbrushing training
Number of subjects: 60
Study: 34453358

Group type: EXPERIMENTAL
Intervention: guselkumab 100 mg
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: guselkumab 200 mg
Number of subjects: 133

Group type: COMPARATOR
Intervention: guselkumab 100 mg (after placebo)
Number of subjects: 133

Group type: COMPARATOR
Intervention: guselkumab 200 mg (after placebo)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: guselkumab (both dosages)
Number of subjects: 133
Study: 35875346

Group type: EXPERIMENTAL
Intervention: Garlic tablets (500 mg, 2 tab/day)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 32594587

Group type: EXPERIMENTAL
Intervention: Cognitive Functional Therapy (CFT)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Group exercise and education intervention
Number of subjects: 206
Study: 33333526

Group type: EXPERIMENTAL
Intervention: Stress Management Program (SMP)
Number of subjects: 59
Study: 34110699

Group type: EXPERIMENTAL
Intervention: Bilateral deployment of HILZO Moving Cell Stents (MCS) using stent-in-stent (SIS) technique
Number of subjects: 27
Study: 35179588

Group type: EXPERIMENTAL
Intervention: Endotracheal intubation (ETI)
Number of subjects: 936

Group type: COMPARATOR
Intervention: Supraglottic airway (SGA)
Number of subjects: 936
Study: 34849433

Group type: EXPERIMENTAL
Intervention: Endotracheal tube introducer (ETI) for right selective intubation
Number of subjects: 46

Group type: COMPARATOR
Intervention: No endotracheal tube introducer for right selective intubation
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Endotracheal tube introducer (ETI) for left selective intubation
Number of subjects: 46

Group type: COMPARATOR
Intervention: No endotracheal tube introducer for left selective intubation
Number of subjects: 46
Study: 32540088

Group type: EXPERIMENTAL
Intervention: Intervention group (organization training, self-management, note-taking instruction)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Intervention group (students willing to follow procedures)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Accommodation group (organization support, extended time, copy of teacher notes)
Number of subjects: 64
Study: 35436153

Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (PTX)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Observation (OBS)
Number of subjects: 191
Study: 33849353

Group type: EXPERIMENTAL
Intervention: Physical activity with cognitive demand (EXCIR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Physical activity without cognitive demand (running, aerobic exercise)
Number of subjects: 30
Study: 32182098

Group type: COMPARATOR
Intervention: Usual care (COPD discharge bundle including PR information leaflet)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Usual care plus the codesigned education video delivered via a handheld tablet device at discharge
Number of subjects: 196
Study: 34628152

Group type: EXPERIMENTAL
Intervention: Multimodal program including mindfulness-based practices, expressive arts, and EMDR group treatment
Number of subjects: 44

Group type: COMPARATOR
Intervention: Care-as-usual control group
Number of subjects: 44
Study: 32575124

Group type: EXPERIMENTAL
Intervention: Tocilizumab (400 mg dose)
Number of subjects: 27
Study: 34008278

Group type: EXPERIMENTAL
Intervention: High-voltage, long-duration pulsed radiofrequency (HL-PRF)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard pulsed radiofrequency (S-PRF)
Number of subjects: 120
Study: 33122540

Group type: EXPERIMENTAL
Intervention: SLAMM+ (multicomponent intervention with height-adjustable workstations)
Number of subjects: 0

Group type: COMPARATOR
Intervention: SLAMM (multicomponent intervention without height-adjustable workstations)
Number of subjects: 0
Study: 32366452

Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Pemetrexed (PEM)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus Pemetrexed (BEV+PEM)
Number of subjects: 90
Study: 35533197

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 0.125 M L‐glutamic acid at 1.65 mL/kg/h
Number of subjects: 303

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 0.125 M L‐glutamic acid at 1.65 mL/kg/h (in patients without diabetes)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Saline (control, in patients without diabetes)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 0.125 M L‐glutamic acid
Number of subjects: 303
Study: 34496276

Group type: EXPERIMENTAL
Intervention: One avocado per day for six months
Number of subjects: 1008

Group type: COMPARATOR
Intervention: Usual diet essentially devoid of avocados
Number of subjects: 1008
Study: 36126237

Group type: EXPERIMENTAL
Intervention: Foot massage (once every day for 7 days)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 70
Study: 33198629

Group type: EXPERIMENTAL
Intervention: Remote Monitoring (RM)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Conventional Monitoring (CM)
Number of subjects: 55
Study: 35045999

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV) applied immediately after extubation combined with high-flow nasal oxygen (HFNO) or standard oxygen between NIV sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxygen therapy alone (HFNO or standard oxygen)
Number of subjects: 0
Study: 34731916

Group type: EXPERIMENTAL
Intervention: Tourniquet use
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Blood loss > 500 cm3
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Postoperative Hb < 10 g/dl
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Blood transfusions
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 100
Study: 32220517

Group type: EXPERIMENTAL
Intervention: Embryogen®/BlastGen™ culture medium
Number of subjects: 100
Study: 2000065592

Group type: EXPERIMENTAL
Intervention: Sultamicillin
Number of subjects: 82

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanic acid
Number of subjects: 82
Study: 35776182

Group type: EXPERIMENTAL
Intervention: TACE with dicycloplatin alone (group A1)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: TACE with dicycloplatin plus epirubicin (group A2)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Epirubicin alone (group B)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 71
Study: 33423006

Group type: EXPERIMENTAL
Intervention: gBRCA1/2 mutations
Number of subjects: 1171

Group type: COMPARATOR
Intervention: wild-type
Number of subjects: 1171

Group type: EXPERIMENTAL
Intervention: gBRCA1 mutations
Number of subjects: 1171
Study: 34076370

Group type: EXPERIMENTAL
Intervention: Family-based behavioural intervention (FBBI)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Waitlist (control)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Family-based behavioural intervention with maintenance (FBBI-M)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Family-based behavioural intervention control (FBBI-C)
Number of subjects: 37
Study: 32557305

Group type: EXPERIMENTAL
Intervention: Risk-based quality management approach in clinical trials with combination products
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combination products in clinical trials
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Metrics for risks and quality management
Number of subjects: 15
Study: 33530241

Group type: EXPERIMENTAL
Intervention: Training set (n = 1299)
Number of subjects: 1856

Group type: EXPERIMENTAL
Intervention: Validation set (n = 557)
Number of subjects: 1856

Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 1856
Study: 32013045

Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich meals until 13:30 and high-fat meals between 16:30 and 22:00
Number of subjects: 29

Group type: COMPARATOR
Intervention: Inverse order of meals (high-fat meals until 13:30 and carbohydrate-rich meals between 16:30 and 22:00)
Number of subjects: 29
Study: 35120544

Group type: EXPERIMENTAL
Intervention: Healthy High School (HHS) intervention
Number of subjects: 4577
Study: 33606023

Group type: EXPERIMENTAL
Intervention: Standard systemic therapy with comprehensive EPC service referral
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard systemic therapy without EPC
Number of subjects: 90
Study: 32604142

Group type: EXPERIMENTAL
Intervention: Supportive care psychosocial interventions
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: General Symptom Distress Scale
Number of subjects: 290
Study: 34801348

Group type: EXPERIMENTAL
Intervention: Bespoke mobile application (My Retainers)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no access to mobile application)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study: 33048260

Group type: EXPERIMENTAL
Intervention: Systemic antibiotics (1 g of amoxicillin, twice daily for 7 days)
Number of subjects: 41

Group type: COMPARATOR
Intervention: No antibiotics (control)
Number of subjects: 41
Study: 32525474

Group type: EXPERIMENTAL
Intervention: Thoracoscopy with 4g of talc poudrage
Number of subjects: 330

Group type: COMPARATOR
Intervention: Chest drain insertion with 4g of talc slurry
Number of subjects: 330
Study: 34996644

Group type: EXPERIMENTAL
Intervention: Message about cancer (HPV causes cervical cancers vs cancers in general)
Number of subjects: 1021

Group type: EXPERIMENTAL
Intervention: Information that it protected against cancers in general
Number of subjects: 1021

Group type: EXPERIMENTAL
Intervention: Providing information about a sexually transmitted infection
Number of subjects: 1021

Group type: EXPERIMENTAL
Intervention: Messaging
Number of subjects: 1021
Study: 33781793

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon
Number of subjects: 212

Group type: COMPARATOR
Intervention: Standard balloon
Number of subjects: 212
Study: 35272757

Group type: EXPERIMENTAL
Intervention: 3D training
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2D training
Number of subjects: 40
Study: 33560235

Group type: EXPERIMENTAL
Intervention: SMS group (motivational messages every 3 days for 6 months)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: SMS group
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 141
Study: 36419818

Group type: EXPERIMENTAL
Intervention: Myofunctional therapy (MT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nonspecific exercises (Control)
Number of subjects: 40
Study: 32144733

Group type: EXPERIMENTAL
Intervention: Video-based learning
Number of subjects: 413

Group type: COMPARATOR
Intervention: Traditional lecture-based learning
Number of subjects: 413
Study: 35914262

Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy (CBT) with interoceptive exposure
Number of subjects: 0
Study: 35679193

Group type: EXPERIMENTAL
Intervention: e-Health StandingTall balance exercise programme
Number of subjects: 503

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 503
Study: 34222709

Group type: EXPERIMENTAL
Intervention: Mindfulness-based smoking cessation app
Number of subjects: 60

Group type: COMPARATOR
Intervention: In-person mindfulness intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study: 34101716

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia with vasopressors to maintain SBP within 10% of pre-operative values
Number of subjects: 230

Group type: COMPARATOR
Intervention: Spinal anaesthesia
Number of subjects: 230
Study: 32702867

Group type: EXPERIMENTAL
Intervention: Early ART initiation (≤14 days after TE diagnosis)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Deferred ART (>14 days after TE diagnosis)
Number of subjects: 200
Study: 34486577

Group type: EXPERIMENTAL
Intervention: Vivinex iSert XY1 (ABC design)
Number of subjects: 85

Group type: COMPARATOR
Intervention: AcrySof IQ SN60WF (posterior aspheric design)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both IOLs
Number of subjects: 85
Study: 33781218

Group type: EXPERIMENTAL
Intervention: High education level and full-time employment with mild physical activity
Number of subjects: 450

Group type: COMPARATOR
Intervention: Low education level and part-time or no employment
Number of subjects: 450